Laven S.A.

Laven is a groundbreaking Poland-based startup that has made a mark in the insurance and health insurance industries with its pioneering offering. Founded in 2021, Laven has secured a significant PLN3.80M investment through a Seed Round led by 4growth VC on 10 April 2022, showcasing strong investor confidence in its potential. Laven's slogan "LAVEN - Complementary Health Insurance. Access to personalized and innovative medicine in Poland" captures the essence of its value proposition. The company provides a unique comprehensive health insurance solution in Poland, bridging the gap by offering coverage for drugs and medical devices not supported under the basic health care provided by the National Health Fund. Notably, it guarantees access to cutting-edge medical technologies, innovative drugs, and select medical devices, along with convenient treatment at premier centers in Poland, free from queues and extra charges. Furthermore, Laven's insurance policy encompasses the acquisition of drugs or medical devices, coordination of therapy using specific medical technologies, and the coverage of associated administration costs. In addition to these services, the startup offers access to medical e-consultations and remote Second Medical Opinions, allowing for professional medical advice and specialist treatment plans from leading global healthcare centers. Laven's innovative approach has positioned it as a trailblazer in providing tailored and progressive healthcare solutions, addressing unmet needs in the Polish market. With its recent investment injection, Laven is primed for further expansion and potential industry disruption, cementing its status as a standout player in the evolving health insurance landscape.